TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GNTA

Genenta Science SpA

Healthcare · Biotechnology

0.6853$ +2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Genenta Science SpA (GNTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -6.9 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Cash Flow GNTA
Line item 2019 2020 2021 2022 2023 2024 2025
-2.5 -6.0 -7.0 -7.4 -11 -6.2 -6.9
0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.7 0.5 0.5 0.7 0.7 0.8 1.0
0.8 0.5 0.8 0.8 – – –
1.4 -0.9 -1.9 0.2 -0.4 1.7 -1.6
0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 -15 6.9 -15
– – – – 0.0 0.0 7.5
15 1.4 29 0.0 0.0 0.3 22
12 -4.7 22 -7.4 -26 0.9 0.9
-2.5 -6.1 -7.0 -7.4 -11 -6.2 -6.9

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?